Carboxyrhodamine 110-PEG3-Azide
Code | Size | Price |
---|
TAR-T14873-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T14873-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Carboxyrhodamine 110-PEG3-Azide is a polyethylene glycol (PEG)-based linker used for the synthesis of Proteolysis Targeting Chimeras (PROTACs) [1].
CAS:
1536327-95-3
Formula:
C58H60N12O14
Molecular Weight:
1149.188
Purity:
0.98
SMILES:
Nc1ccc2c(-c3ccc(cc3C([O-])=O)C(=O)NCCOCCOCCOCCN=[N+]=[N-])c3ccc(N)cc3[o+]c2c1.Nc1ccc2c(-c3cc(ccc3C([O-])=O)C(=O)NCCOCCOCCOCCN=[N+]=[N-])c3ccc(N)cc3[o+]c2c1
References
An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562